Spriaso Announces Approval of New Drug Application for the Long Acting Codeine Antitussive With a Popular Anti-Histamine SALT LAKE CITY, July 1, 2015 (GLOBE NEWSWIRE) -- Spriaso LLC. (www.spriasollc.com), today announced FDA approval of a New Drug Application (NDA) for Tuxarin ER®, a unique high strength long...

Spriaso Announces Filing of New Drug Application for the First Long Acting Codeine Antitussive With a Popular Antihistamine SALT LAKE CITY, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Spriaso LLC. (www.spriasollc.com), today announced FDA acceptance of a New Drug Application (NDA) to seek approval for Rinotuss12®, a unique Rx...